Clinical trial
Prevention of Thromboembolism Using Apixaban vs Enoxaparin Following Spinal Cord Injury
NCT05484557 is registered in ClinicalTrials.gov with Loewenstein Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevention of Thromboembolism Using Apixaban vs Enoxaparin Following Spinal Cord Injury
- Lead sponsor
- Loewenstein Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 6, 2023
- Completion date
- February 29, 2028
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.